Carregant...
Liraglutide reduces fatty degeneration in hepatic cells via the AMPK/SREBP1 pathway
Recent studies have suggested that liraglutide could have a potential function in improving non-alcoholic fatty liver disease (NAFLD); however, the underlying molecular mechanism remains unclear. The aim of the present study was to investigate the role of the AMP-activated protein kinase (AMPK)/ster...
Guardat en:
| Publicat a: | Exp Ther Med |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
D.A. Spandidos
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4665609/ https://ncbi.nlm.nih.gov/pubmed/26640549 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2015.2741 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|